26 May 2013
Keywords: novartis, mrsa, drug, cubicin, launched, uk, swiss
Article | 24 September 2007
Swiss drug major Novartis has launched its new antibiotic Cubicin (daptomycin) in the UK for the treatment of both methicillin-sensitive
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 September 2007
24 May 2013
© 2013 thepharmaletter.com